New results for world’s first nicotinamide glaucoma clinical trial

Vitamin B₃ improves visual function in glaucoma patients world-first clinical trial demonstrates!

Read the new paper by Hui et al. now [PDF].

REF: Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ, Coote M, Trounce IA, Martin KR, van Wijngaarden P, Crowston JG. “Improvement in inner retinal function in glaucoma in response to nicotinamide (vitamin B₃) supplementation: A crossover randomized clinical trial”. Clinical & Experimental Ophthalmology. 2020 (doi: 10.1111/ceo.13818)

Media release by CERA [LINK]

Media release by S:t Eriks Ögonsjukhus [LINK EN] [LINK SV]

News release in Dagens Medicin [LINK SV]

News release in Sveriges Radio [LINK SV & AUDIO]

Categories: Papers